Viking Therapeutics (VKTX) Q4 2025 Earnings

22OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.81
-0.63
-0.45
-0.28

Details

Expected EPS
-0.709556
Actual EPS
-0.81
Surprise EPS
-0.1
Surprise Percent
+14.16%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.81 per share for Q4 2025.

0 Comments

Share your thoughts